Literature DB >> 21441930

A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase.

Trevor Hinkley1, João Martins, Colombe Chappey, Mojgan Haddad, Eric Stawiski, Jeannette M Whitcomb, Christos J Petropoulos, Sebastian Bonhoeffer.   

Abstract

The development of a quantitative understanding of viral evolution and the fitness landscape in HIV-1 drug resistance is a formidable challenge given the large number of available drugs and drug resistance mutations. We analyzed a dataset measuring the in vitro fitness of 70,081 virus samples isolated from HIV-1 subtype B infected individuals undergoing routine drug resistance testing. We assayed virus samples for in vitro replicative capacity in the absence of drugs as well as in the presence of 15 individual drugs. We employed a generalized kernel ridge regression to estimate main fitness effects and epistatic interactions of 1,859 single amino acid variants found within the HIV-1 protease and reverse transcriptase sequences. Models including epistatic interactions predict an average of 54.8% of the variance in replicative capacity across the 16 different environments and substantially outperform models based on main fitness effects only. We find that the fitness landscape of HIV-1 protease and reverse transcriptase is characterized by strong epistasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441930     DOI: 10.1038/ng.795

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  26 in total

1.  Epistatic buffering of fitness loss in yeast double deletion strains.

Authors:  Lukasz Jasnos; Ryszard Korona
Journal:  Nat Genet       Date:  2007-02-25       Impact factor: 38.330

Review 2.  HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.

Authors:  Robert W Shafer; Jonathan M Schapiro
Journal:  AIDS Rev       Date:  2008 Apr-Jun       Impact factor: 2.500

3.  Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1.

Authors:  J Martinez-Picado; A V Savara; L Sutton; R T D'Aquila
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 4.  Rationale and uses of a public HIV drug-resistance database.

Authors:  Robert W Shafer
Journal:  J Infect Dis       Date:  2006-09-15       Impact factor: 5.226

5.  Evidence for positive epistasis in HIV-1.

Authors:  Sebastian Bonhoeffer; Colombe Chappey; Neil T Parkin; Jeanette M Whitcomb; Christos J Petropoulos
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

6.  Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.

Authors:  Diane E Bennett; Ricardo J Camacho; Dan Otelea; Daniel R Kuritzkes; Hervé Fleury; Mark Kiuchi; Walid Heneine; Rami Kantor; Michael R Jordan; Jonathan M Schapiro; Anne-Mieke Vandamme; Paul Sandstrom; Charles A B Boucher; David van de Vijver; Soo-Yon Rhee; Tommy F Liu; Deenan Pillay; Robert W Shafer
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

7.  Distribution of human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing.

Authors:  Soo-Yon Rhee; Tommy Liu; Jaideep Ravela; Matthew J Gonzales; Robert W Shafer
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

8.  The genetic landscape of a cell.

Authors:  Michael Costanzo; Anastasia Baryshnikova; Jeremy Bellay; Yungil Kim; Eric D Spear; Carolyn S Sevier; Huiming Ding; Judice L Y Koh; Kiana Toufighi; Sara Mostafavi; Jeany Prinz; Robert P St Onge; Benjamin VanderSluis; Taras Makhnevych; Franco J Vizeacoumar; Solmaz Alizadeh; Sondra Bahr; Renee L Brost; Yiqun Chen; Murat Cokol; Raamesh Deshpande; Zhijian Li; Zhen-Yuan Lin; Wendy Liang; Michaela Marback; Jadine Paw; Bryan-Joseph San Luis; Ermira Shuteriqi; Amy Hin Yan Tong; Nydia van Dyk; Iain M Wallace; Joseph A Whitney; Matthew T Weirauch; Guoqing Zhong; Hongwei Zhu; Walid A Houry; Michael Brudno; Sasan Ragibizadeh; Balázs Papp; Csaba Pál; Frederick P Roth; Guri Giaever; Corey Nislow; Olga G Troyanskaya; Howard Bussey; Gary D Bader; Anne-Claude Gingras; Quaid D Morris; Philip M Kim; Chris A Kaiser; Chad L Myers; Brenda J Andrews; Charles Boone
Journal:  Science       Date:  2010-01-22       Impact factor: 47.728

9.  Positive selection detection in 40,000 human immunodeficiency virus (HIV) type 1 sequences automatically identifies drug resistance and positive fitness mutations in HIV protease and reverse transcriptase.

Authors:  Lamei Chen; Alla Perlina; Christopher J Lee
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 10.  Clinical significance of human immunodeficiency virus type 1 replication fitness.

Authors:  Carrie Dykes; Lisa M Demeter
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

View more
  97 in total

1.  Epistasis can lead to fragmented neutral spaces and contingency in evolution.

Authors:  Steffen Schaper; Iain G Johnston; Ard A Louis
Journal:  Proc Biol Sci       Date:  2011-12-07       Impact factor: 5.349

2.  Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity.

Authors:  Mark A Brockman; Denis R Chopera; Alex Olvera; Chanson J Brumme; Jennifer Sela; Tristan J Markle; Eric Martin; Jonathan M Carlson; Anh Q Le; Rachel McGovern; Peter K Cheung; Anthony D Kelleher; Heiko Jessen; Martin Markowitz; Eric Rosenberg; Nicole Frahm; Jorge Sanchez; Simon Mallal; Mina John; P Richard Harrigan; David Heckerman; Christian Brander; Bruce D Walker; Zabrina L Brumme
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

3.  Environmental change exposes beneficial epistatic interactions in a catalytic RNA.

Authors:  Eric J Hayden; Andreas Wagner
Journal:  Proc Biol Sci       Date:  2012-06-20       Impact factor: 5.349

4.  Adaptive walks on the fitness landscape of music.

Authors:  Christoph Adami
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

5.  Comprehensive experimental fitness landscape and evolutionary network for small RNA.

Authors:  José I Jiménez; Ramon Xulvi-Brunet; Gregory W Campbell; Rebecca Turk-MacLeod; Irene A Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

6.  High-throughput identification of genetic interactions in HIV-1.

Authors:  Daniel M Weinreich
Journal:  Nat Genet       Date:  2011-05       Impact factor: 38.330

7.  The Valley-of-Death: reciprocal sign epistasis constrains adaptive trajectories in a constant, nutrient limiting environment.

Authors:  Kami E Chiotti; Daniel J Kvitek; Karen H Schmidt; Gregory Koniges; Katja Schwartz; Elizabeth A Donckels; Frank Rosenzweig; Gavin Sherlock
Journal:  Genomics       Date:  2014-11-01       Impact factor: 5.736

8.  Minimum epistasis interpolation for sequence-function relationships.

Authors:  Juannan Zhou; David M McCandlish
Journal:  Nat Commun       Date:  2020-04-14       Impact factor: 14.919

9.  Design requirements for interfering particles to maintain coadaptive stability with HIV-1.

Authors:  Igor M Rouzine; Leor S Weinberger
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

10.  Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design.

Authors:  Andrew L Ferguson; Jaclyn K Mann; Saleha Omarjee; Thumbi Ndung'u; Bruce D Walker; Arup K Chakraborty
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.